DIABETIC NEUROPATHY, PAINFUL
Clinical trials for DIABETIC NEUROPATHY, PAINFUL explained in plain language.
Never miss a new study
Get alerted when new DIABETIC NEUROPATHY, PAINFUL trials appear
Sign up with your email to follow new studies for DIABETIC NEUROPATHY, PAINFUL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Foot exercises show promise for diabetic nerve pain relief
Symptom relief CompletedThis study tested whether a set of foot and ankle exercises could reduce pain and improve quality of life in 100 people with painful diabetic neuropathy. Participants performed exercises like ankle circles, toe spreads, and rolling a warm bottle under the foot. Researchers measur…
Matched conditions: DIABETIC NEUROPATHY, PAINFUL
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Engensis pain treatment checked for Long-Term safety
Symptom relief CompletedThis study followed 101 people who had previously received either the experimental drug Engensis or a placebo for painful diabetic neuropathy. No new treatment was given; researchers simply monitored participants for 6 months to see if any safety issues or lasting pain relief app…
Matched conditions: DIABETIC NEUROPATHY, PAINFUL
Phase: PHASE3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Gene therapy shot aims to ease diabetic foot pain
Symptom relief CompletedThis Phase 3 study tested whether injections of engensis, a gene therapy, can reduce pain in the feet and legs caused by diabetic nerve damage. 162 adults with type 1 or 2 diabetes received either engensis or a placebo. The main goal was to see if pain scores improved over 180 da…
Matched conditions: DIABETIC NEUROPATHY, PAINFUL
Phase: PHASE3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Gene therapy shot aimed at diabetic nerve pain put to the test
Symptom relief CompletedThis study tested whether a gene therapy called VM202 could safely reduce pain in people with diabetic peripheral neuropathy. Over 500 adults with type 1 or type 2 diabetes received either VM202 injections or a placebo in their legs. The main goal was to see if the treatment lowe…
Matched conditions: DIABETIC NEUROPATHY, PAINFUL
Phase: PHASE3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC